KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Asset Writedowns and Impairment (2016 - 2025)

Petmed Express' Asset Writedowns and Impairment history spans 13 years, with the latest figure at -$6000.0 for Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$6000.0; the TTM value through Dec 2025 reached $35000.0, down 87.08%, while the annual FY2025 figure was $365000.0, 12.65% up from the prior year.
  • Asset Writedowns and Impairment reached -$6000.0 in Q2 2025 per PETS's latest filing, down from $41000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $271000.0 in Q1 2024 to a low of -$78000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 5 years is $52266.7, with a median of $29000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: tumbled 227.87% in 2023, then surged 447.44% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $46000.0 in 2021, then skyrocketed by 391.3% to $226000.0 in 2022, then tumbled by 92.48% to $17000.0 in 2023, then soared by 1494.12% to $271000.0 in 2024, then tumbled by 102.21% to -$6000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Asset Writedowns and Impairment are -$6000.0 (Q2 2025), $41000.0 (Q1 2025), and $271000.0 (Q1 2024).